Genelabs Biotechnology, Genelabs, Long Bon Development Co. deal

GNLB raised $4.3 million through the sale of an undisclosed number of shares of its Genelabs Biotechnology affiliate to Long Bon Development at NT$17.50 (US$0.51) per share. The sale reduces GNLB’s st...